interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Eplontersen Sodium

Generic competition · all medicines · read 12 November 2026

Is there a generic of Eplontersen Sodium, and who makes it?

Eplontersen Sodium appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Eplontersen Sodium1 dosage-form group in the Orange Book
0generic makers listed
  1. Eplontersen Sodium appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Solution, Subcutaneous

Brand listed, no generic listed as marketed

Brand listed as marketed: Wainua and Wainua (Autoinjector). No generic is listed as marketed.

202020252030203501brand 2023data datePatent 9181549 listed to expire 1 May 2034Patent 9127276 listed to expire 1 May 2034Patent 10683499 listed to expire 25 August 2034Exclusivity NCE to 21 December 2028Exclusivity ODE-461 to 21 December 2030
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 21 December 2028Exclusivity NCE Wainua (Autoinjector)
  • 21 December 2030Exclusivity ODE-461 Wainua (Autoinjector)
  • 1 May 2034Patent 9181549 drug substance
  • 1 May 2034Patent 9127276 drug substance
  • 25 August 2034Patent 10683499 drug substance

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.